Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
Fexlamose is being developed as a chronic treatment for COPD and asthma in conjunction with standard therapies, to improve ...
Young teens might think smoking makes them look cool, but it’s likely to take their breath away in adulthood, a new st ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve holistic patient care, according to a new editorial.
Childhood smoking before age 15 increases a person's risk of developing chronic obstructive pulmonary disease (COPD), ...
A study reveals childhood smoking significantly increases COPD risk in adulthood, highlighting the need for targeted ...
For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
In 2021,138,825 people died from COPD in the U.S., making it the sixth overall leading cause of death and the fifth ...
Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...